Nucleoside/nucleotide Reverse Transcriptase Inhibitor Sparing Regimen with Once Daily Integrase Inhibitor Plus Boosted Darunavir is Non-Inferior to Standard of Care in Virologically-Suppressed Children and Adolescents Living with HIV – Week 48 Results of the Randomised SMILE Penta-17-ANRS 152 Clinical Trial
ECLINICALMEDICINE（2023）
Key words
HIV,Children,Adolescents,Randomised,Paediatrics,Dual therapy,Maintenance,Simplification,Dolutegravir,Darunavir,Virological suppressed
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined